I-ChowJoeHsuMDFASTRO

Radiation Oncology • San Francisco, CA

Gynecologic Cancer, Urologic Cancer

Professor

Join to view full profile

Dr. Hsu is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Hsu's full profile

Already have an account?

Office
UCSF Helen Diller Family Comprehensive Cancer Center
1600 Divisadero St H1031
San Francisco, CA 94115
Phone+1 415-353-7175

Fax+1 415-353-9883

Summary

Dr. I-Chow Hsu is a radiation oncologist in San Francisco, CA and is affiliated with multiple hospitals in the area, including UCSF Medical Center, San Francisco VA Medical Center, and Zuckerberg San Francisco General Hospital and Trauma Center. He received his medical degree from Johns Hopkins University School of Medicine and has been in practice 26 years. He also speaks multiple languages, including Chinese (Mandarin). He specializes in gynecologic cancer and urologic cancer and is experienced in brachytherapy and hyperthermic radiosensitization.

Education & Training

New York Presbyterian Hospital (Columbia Campus)Residency, Radiation Oncology, 1992 - 1995
Arrowhead Regional Medical CenterInternship, Transitional Year, 1991 - 1992
Johns Hopkins University School of MedicineClass of 1991

Certifications & Licensure

CA State Medical License 1992 - 2026
American Board of Radiology Radiation Oncology

Awards, Honors, & Recognition

Regional Top Doctor Castle Connolly, 2014

Clinical Trials

Radiation Therapy in Treating Patients With Stage II or Stage III Prostate Cancer Start of enrollment: 2004 Jul 01
Completed
Phase 2
Pilot Study of a Catheter-based Ultrasound Hyperthermia System Start of enrollment: 2009 Dec 18
Terminated
Not Applicable
Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer Start of enrollment: 2009 Sep 01
Active, not recruiting
Phase 3
Focal Salvage HDR Brachytherapy for Locally Recurrent Prostate Cancer in Patients Treated With Prior Radiotherapy Start of enrollment: 2017 Aug 28
Recruiting
Phase 1, Phase 2
High Dose Rate Prostate Brachytherapy: Dose Escalation to Dominant Intra-prostatic Nodule Start of enrollment: 2012 May 01
Completed
Not Applicable
Join now to see all

Publications & Presentations

PubMed

Consensus Guidelines for Delineation of Clinical Target Volumes for Intensity-Modulated Radiotherapy for Intact Cervical Cancer: An Update.
Emma C Fields, Walter R Bosch, Kevin V Albuquerque, Rohini Bhatia, Junzo Chino
Practical Radiation Oncology. 2024-11-13
Safety of high-dose-rate brachytherapy in patients with prostate cancer and inflammatory bowel disease: A case series.
Horatio Thomas, Jie Jane Chen, Haitham Shaheen, Ali Sabbagh, Hasan Abdul-Baki
Journal of Contemporary Brachytherapy. 2024-02-01
Treatment Planning Strategies for Interstitial Ultrasound Ablation of Prostate Cancer.
Pragya Gupta, Tamas Heffter, Muhammad Zubair, I-Chow Hsu, E Clif Burdette
IEEE Open Journal of Engineering in Medicine and Biology. 2024-01-01

Other Languages

Chinese (Mandarin)